Colchicine in Patients with Chronic Coronary Disease.
Explore this paper's citation graph
Summary
In a randomized trial involving patients with chronic coronary disease, the risk of cardiovascular events was significantly lower among those who received 0.5 mg of colchicine once daily than among thoseWho received placebo.
- Type
- article
- Published
- 2020-08-31
- Cited by
- 1,757
- References
- 19
- Access
- Open access
- OpenAlex
- https://openalex.org/W3081761942
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:221382397
Keywords
Colchicine, Medicine, Myocardial infarction, Internal medicine, Cardiology
References
- Atherosclerosis--an inflammatory disease.
- Colchicine --- update on mechanisms of action and therapeutic uses
- Low-dose colchicine for secondary prevention of cardiovascular disease.
- Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils.
- Mechanism of action of colchicine in the treatment of gout.
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- New Guidelines for Statistical Reporting in the Journal.
- The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
- Atherosclerosis — An Inflammatory Disease
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
Cited by
- Assessment of Nonfatal Myocardial Infarction as a Surrogate for All-Cause and Cardiovascular Mortality in Treatment or Prevention of Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials.
- Lo mejor del 2020: estudios que marcarán nuestra práctica clínica
- Myeloid But Not Endothelial Expression of the CB2 Receptor Promotes Atherogenesis in the Context of Elevated Levels of the Endocannabinoid 2-Arachidonoylglycerol
- Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention?
- Low-dose colchicine shows promise in chronic coronary disease
- Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well
- Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Repurposing Colchicine to Combat Residual Cardiovascular Risk: The LoDoCo2 Trial
- Colchicine for the Treatment of Coronary Artery Disease.
- ESC Congress 2020, the digital experience: a report from the ESC Scientists of Tomorrow
- [In patients with stable chronic coronary disease, how effective is colchicine in preventing cardiovascular events and what are the adverse reactions when compared to placebo?]
- HOT lines na sjezdu ČKS 2020
- Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis
- A tale of two therapies lipid-lowering vs anti-inflammatory therapy - a false dichotomy?
- Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction
- Genetic determinants of COVID-19 drug efficacy revealed by genome-wide CRISPR screens
- Embracing colchicine as a new cornerstone therapy for coronary disease.
- Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease.
- Atherosclerotic Plaque Disruption and Healing.
- Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis
Related papers
- How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project.
- Analysis of the Treatment of Coronary Heart Disease
- The Study of Comparison between Treadmill Test and Coronary Arteriongraphy
- Coronary proneness and approaches to preventing heart attacks.
- Serum cholesterol and death from coronary heart disease.
- The absence of excess coronary heart disease among the elderly in the continuation of cigarette smoking A Reply
- [The role of coronary vasodilatators in the treatment of coronary heart disease].